Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies. Kurdi, M., Butt, N., S., Baeesa, S., Alghamdi, B., Maghrabi, Y., Bardeesi, A., Saeedi, R., Dallol, A., Mohamed, F., Bari, M., O., & others Journal of Neuro-Oncology, 152(3):541-549, Springer US, 2021.
bibtex   1 download  
@article{
 title = {Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies},
 type = {article},
 year = {2021},
 pages = {541-549},
 volume = {152},
 publisher = {Springer US},
 id = {a3e460c0-cefb-34bb-9fa8-e0db3c5475a1},
 created = {2022-01-02T16:36:32.354Z},
 file_attached = {false},
 profile_id = {49efd9d1-b84a-3562-b8db-36e64ac7ba81},
 last_modified = {2022-01-02T16:36:32.354Z},
 read = {false},
 starred = {false},
 authored = {true},
 confirmed = {true},
 hidden = {false},
 citation_key = {kurdi2021prognostic},
 source_type = {article},
 private_publication = {false},
 bibtype = {article},
 author = {Kurdi, Maher and Butt, Nadeem Shafique and Baeesa, Saleh and Alghamdi, Badrah and Maghrabi, Yazid and Bardeesi, Anas and Saeedi, Rothaina and Dallol, Ashraf and Mohamed, Fawaz and Bari, Mohammed O and others, undefined},
 journal = {Journal of Neuro-Oncology},
 number = {3}
}

Downloads: 1